SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-004613
Filing Date
2022-03-29
Accepted
2022-03-29 16:17:15
Documents
13
Period of Report
2022-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20220329x8k.htm   iXBRL 8-K 36364
2 EX-99.1 ampe-20220329xex99d1.htm EX-99.1 160209
  Complete submission text file 0001558370-22-004613.txt   328622

Data Files

Seq Description Document Type Size
3 EX-101.SCH ampe-20220329.xsd EX-101.SCH 3286
4 EX-101.LAB ampe-20220329_lab.xml EX-101.LAB 15367
5 EX-101.PRE ampe-20220329_pre.xml EX-101.PRE 10382
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20220329x8k_htm.xml XML 4676
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 22781016
SIC: 2834 Pharmaceutical Preparations